Abstract

Purpose. For the study of pharmacokinetics of sildenafil oral spray “Tegrum”, developed by pharmaceutical company “Microkhim” (Rubezhnoe, Ukraine) with the aim to improve the pharmacokinetic characteristics of existing solid formulations for oral use it was worked out and validated a rapid, simple and specific method of quantitative determination of sildenafil concentration in human plasma using internal standard labeled with 8 deuterium atoms - sildenafil-d8.Methods. Sildenafil was extracted from plasma by the liquid-liquid extraction, and quantitatively determined in supernatant by means of а high performance liquid chromatography - tandem mass spectrometry method (HPLC-MS/MS). Separation of components was performed using the chromatographic column Kinetex 2.6u C18, 50 x 4.6 mm, 2.6 μm (Phenomenex) at 45˚C at isocratic elution mode and mobile phase, that consisted of 2 mM aqueous ammonium acetate solution (pH 5,45 ± 0,05) and acetonitrile (10/90, vol./vol.); flow rate equaled to 0.4 ml/min. Ionization of sildenafil and sildenafil-d8 was performed in the positive electrospray mode (ESI, Positive). Multi reactions monitoring (MRM) mode was used for selected daughter and parent ions detection with the following settings of the mass spectrometer: m/z 475,20/283,20 and 483.20/283.20 for sildenafil and sildenafil-d8 respectively.Results. The method described above was validated in the linear range 10,00-400,00 ng/mL of sildenafil with a correlation coefficient (r2) 0,99764 and demonstrated reliable accuracy and reproducibility of results.Conclusions. Utilization of elaborated method of fast direct liquid - liquid sildenafil extraction from the blood plasma with simultaneous proteins precipitation, avoiding commonly used supernatant evaporation and subsequent restoration of dry residue at preanalytical stage allowed to achieve target sensitivity of determination and reduced the analysis runtime. Usage of the deuterated internal standard (sildenafil-d8) at analytical stage gave an opportunity to reduce the limit of quantification, to achieve high sensitivity and specificity, as well as suppress matrix effect. Rather high analytical characteristics of the method proposed allow its application in routine bioanalysis during pharmacokinetic studies.

Highlights

  • For the study of pharmacokinetics of sildenafil oral spray “Tegrum”, developed by pharmaceutical company “Microkhim” (Rubezhnoe, Ukraine) with the aim to improve the pharmacokinetic characteristics of existing solid formulations for oral use it was worked out and validated a rapid, simple and specific method of quantitative determination of sildenafil concentration in human plasma using internal standard labeled with 8 deuterium atoms – sildenafil-d8

  • Sildenafil was extracted from plasma by the liquid-liquid extraction, and quantitatively determined in supernatant by means of а high performance liquid chromatography – tandem mass spectrometry method (HPLC-MS/MS)

  • Multi reactions monitoring (MRM) mode was used for selected daughter and parent ions detection with the following settings of the mass spectrometer: m/z 475,20/283,20 and 483.20/283.20 for sildenafil and sildenafil-d8 respectively

Read more

Summary

Среднее значение

Примечание: LLOQ – нижний предел количественного определения; QCL – низкий QC (в пределах трехкратного LLOQ); QCМ – средний QC (приблизительно 50 % от диапазона калибровочной кривой, QCН – высокий QC (не менее 75 % верхней границы диапазона калибровочной кривой). 3, для образцов «НПКО» средняя концентрация находилась в пределах 20,00 % от номинального значения, для образцов QCL, QCМ и QCН – 15,00 % от номинальных значений. Прецизионность, оцениваемая по показателю коэффициента вариации (CV), для LLOQ не превышала 20,00 %, для низких, средних и высоких образцов QC – 15,00 %, что свидетельствует о соответствии правильности и прецизионности метода требованиям регуляторных документов [18,19,20]. Степень извлечения силденафила из плазмы крови человека определялась сравнением площадей пиков проб, экстрагированных образцов, с площадями пиков неэкстрагированных образцов, принимаемых за 100 %. Средняя степень извлечения силденафила из плазмы крови человека составила 101,04 %. Результаты определения степени извлечения силденафила из плазмы крови представлены в табл. Результаты определения степени извлечения силденафила из плазмы крови представлены в табл. 4

Результаты определения степени извлечения силденафила из плазмы крови
Стабильность силденафила в образцах
Рабочие растворы силденафила
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call